InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the full record of transactions filed by Jones Erika, Autre. Director active across 1 company, notably Black Diamond Therapeutics, Inc.. Aggregated, 3 disclosures have been published. History available since 15 February 2022. The latest transaction was disclosed on 30 January 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条
Erika Jones is involved in various functions at Black Diamond Therapeutics, Inc. While the details of her role are not specified, she contributes to the company's mission in the biopharmaceutical sector. Her expertise is valuable for developing innovative solutions.